Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT06143631 · ClinicalTrials.gov registry record · Phase 4
Prescription of Letrozole for Uterine Myoma
A Phase 4 study of Leiomyoma and Fibroid Uterus, sponsored by University of California, San Francisco.
- Recruiting
- Registry status
- Phase 4
- Development phase
- 140
- Enrollment target
- 5
- Study locations
NCT06143631 is a Phase 4 study of Leiomyoma and Fibroid Uterus that is actively recruiting participants, run by University of California, San Francisco. The registered enrollment target is 140 participants, above the 88-participant average among 8 other Leiomyoma trials with a reported enrollment target (59% higher). The trial reports 5 study locations across 4 states.
The verdict
NCT06143631, a Phase 4 study of Leiomyoma and Fibroid Uterus, is actively recruiting participants, sponsored by University of California, San Francisco.
- RECRUITING
- Registry status
- Phase 4
- Development phase
- 140 participants
- Enrollment target
- 5
- Study locations
Study Summary
The PLUM Study is a randomized, double-blinded, 2-arm, parallel-group, placebo-controlled trial is designed to compare the efficacy of letrozole versus placebo on leiomyoma-related symptoms and quality of life as well as leiomyoma and uterine size.
Conditions Studied
Interventions
- OTHER Placebo
- DRUG Letrozole 2.5mg
Study Locations (5)
California
- University of California, Los Angeles - Los Angeles
- University of California, San Francisco - San Francisco
Minnesota
- Mayo Clinic - Rochester
Mississippi
- University of Mississippi Medical Center - Jackson
North Carolina
- Duke University - Durham
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 140 participants |
| Start Date | 2024-07-24 |
| Est. Completion | 2027-04-30 |
| Phase | Phase 4 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT06143631
The ClinicalTrials.gov registry entry for NCT06143631 describes a study currently listed as recruiting, categorized as Phase 4. The registered enrollment target is 140 participants, a figure that helps gauge the scale of data the investigators plan to collect, above the 88-participant average among 8 other Leiomyoma trials with a reported enrollment target (59% higher). The listed sponsor is University of California, San Francisco, which has 1,713 total studies on file at ClinicalTrials.gov.
The record links to 4 conditions, with Leiomyoma appearing as the primary indexed condition, and to 2 interventions - of which Placebo is the first listed.
NCT06143631 reports 5 study locations spanning 4 distinct geographic areas - top geographies include California, Minnesota, Mississippi.
Frequently Asked Questions
What is clinical trial NCT06143631 about?
NCT06143631 is a clinical study titled "Prescription of Letrozole for Uterine Myoma". The PLUM Study is a randomized, double-blinded, 2-arm, parallel-group, placebo-controlled trial is designed to compare the efficacy of letrozole versus placebo on leiomyoma-related symptoms and quality of life as well as leiomyoma and uterine size.
What is the current status of trial NCT06143631?
This trial is currently recruiting. It is a Phase 4 study. The enrollment target is 140 participants. The study started on 2024-07-24. Estimated completion is 2027-04-30.
What conditions does trial NCT06143631 study?
This clinical trial studies the following conditions: Leiomyoma, Fibroid Uterus, Leiomyoma, Uterine, Fibroid.
What interventions are being tested in trial NCT06143631?
The interventions under investigation include: Placebo (OTHER), Letrozole 2.5mg (DRUG).
Who is sponsoring clinical trial NCT06143631?
This trial is sponsored by University of California, San Francisco, which has 1,713 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT06143631 being conducted?
This trial has 5 study locations across California, Minnesota, Mississippi, North Carolina. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Leiomyoma
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
An Open-Label Study to Evaluate the Effect of Elix Cycle Balance & Elix Daily Harmony on Fibroid-related Symptoms
RECRUITING · NA
-
Role of Senescent Cells in Uterine Fibroid Pathogenesis (SOUL Study)
RECRUITING
-
Effects of Simvastatin on Uterine Leiomyoma Size
RECRUITING · Phase 2
-
Surgical Success After Laparoscopic vs Abdominal Hysterectomy
COMPLETED · NA
-
Treatment of Uterine Fibroids With the Selective Progesterone Receptor Modulator CDB-2914
COMPLETED · Phase 2
-
A Study of the Efficacy and Safety of a 3-month Treatment Course of Ulipristal Acetate for the Treatment of Abnormal Uterine Bleeding Associated With Leiomyomas
COMPLETED · Phase 3
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.